Molecular/biomarker testing in lung cytology: A practical approach

• Type: Article in International Scientific Journal
• Date: 2022

Authors

Fernando Schmitt (Author) FMUP; Lozano, MD (Author) Other

Journal

Title: Diagnostic Cytopathology

Vol. 51

Pages: 59-67

ISSN: 8755-1039

Publisher: Wiley-Blackwell

Indexing

ISI Web of Knowledge - 7 Citations

Scopus - 6 Citations

Other information

Authenticus ID: P-00X-6V5

DOI: 10.1002/dc.25054

Abstract (EN): The increasing comprehension of molecular mechanisms underlying lung cancer and the discovery of targetable genomic alterations has dramatically change the pathological approach to lung cancer, especially non-small cell lung cancer (NSCLC). This unstoppable knowledge has taken pathologists to the leading front on lung cancer management. This is especially relevant in the world of cytopathology where doing more with less is a daily challenge. Nowadays with a growing number of predictive biomarkers needed to manage patients with NSCLC, there has been a paradigm shift in care and handling of diagnostic samples. One of the main emphasis and interest relies on the utilization of cytologic samples and small biopsies for not only diagnostic purposes but also for ancillary testing. Moreover, lung cytopathology is in continuous evolutions with implementation of new diagnostic techniques, new tools, and facing new challenges. The goal of this paper will be to provide the reader with the necessary concepts than can be used to exploit the cytological samples in order to use these samples for comprehensive diagnosis and relevant ancillary testing purposes.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 9